Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|November 3, 2011
Altering host resistance to infections through microbial transplantationBenjamin P Willing, Anjalee Vacharaksa, Matthew Croxen, et al.
Epidemiology and Infection|December 23, 2024
Group A streptococcal infections in Alberta, Canada 2018-2023Gregory J Tyrrell, Matthew Croxen, Emily McCullough, et al.
Eclinicalmedicine|January 17, 2022
How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new toolsLeyla Asadi, Matthew Croxen, Courtney Heffernan, et al.
Infection and Immunity|April 22, 2015
The Serine Protease Autotransporter Pic Modulates Citrobacter rodentium Pathogenesis and Its Innate Recognition by the HostKirandeep Bhullar, Maryam Zarepour, Hongbing Yu, et al.
The Journal of Infection|December 17, 2023
The association between phylogenetic lineage and the subclinical phenotype of pulmonary tuberculosis: A retrospective 2-cohort studyRichard Long, Matthew Croxen, Robyn Lee, et al.
Science Advances|September 14, 2019
Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized miceManisha Pandey, Ainslie Calcutt, Victoria Ozberk, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Retrospective testing of respiratory specimens for COVID-19 to assess for earlier SARS-CoV-2 infections in Alberta, CanadaJamil N Kanji, Mathew Diggle, Dennis E Bulman, et al.
Emerging Infectious Diseases|November 22, 2021
Characterization of Swine Influenza A(H1N2) Variant, Alberta, Canada, 2020Jamil N Kanji, Kanti Pabbaraju, Matthew Croxen, et al.
Nature Communications|October 2, 2025
The assembly of a hybrid type IV secretion system by a Crohn's disease-associated Escherichia coli strainJonas Wong, Ahmad Refaat, Pablo Villacampa-Teixeira, et al.
Vaccine|September 5, 2021
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1John Lok Man Law, Michael Logan, Michael A Joyce, et al.
Pageof 2